TransCelerate BioPharma Launches Three New Initiatives and Expands Membership

TransCelerate announced it has committed to an expansion of its clinical and drug safety portfolio, revealing three new initiatives: the Common Clinical Serious Adverse Events Fields Initiative, the Modernization of Data Analytics for Clinical Development Initiative and the Interpretation of Guidances and Regulations Initiative.

Translate ยป

Stay Connected to TransCelerate.